New brain wafer fights deadly recurrent cancer
NCT ID NCT07349693
Summary
This study is testing whether adding a new, implantable wafer (Cerebraca Wafer) to standard chemotherapy (temozolomide) helps people live longer with recurrent glioblastoma, a very aggressive brain cancer. The wafer is placed in the brain during surgery to remove the tumor. Researchers will compare survival and safety in about 175 adults whose cancer has come back after initial treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA, IDH-WILDTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Legorreta Cancer Center Warren Alpert Medical School of Brown University
Providence, Rhode Island, 02903, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.